Athenex Inc.

1.1000.00Vol 2.74M1Y Perf -69.86%
Aug 9th, 2022 16:00 DELAYED
BID1.08 ASK1.12
Open1.10 Previous Close1.10
Pre-Market- After-Market1.06
 - -  -0.04 -3.64%
Target Price
3.00 
Analyst Rating
Moderate Buy 2.00
Potential %
172.73 
Finscreener Ranking
+     38.79
Insiders Trans % 3/6/12 mo.
-/-/100 
Value Ranking
     33.58
Insiders Value % 3/6/12 mo.
-/-/100 
Growth Ranking
+     31.76
Insiders Shares Cnt. % 3/6/12 mo.
-/-/100 
Income Ranking
 —    -
Price Range Ratio 52W %
19.83 
Earnings Rating
Strong Sell
Market Cap133.77M 
Earnings Date
28th Jul 2022
Alpha-0.05 Standard Deviation0.19
Beta0.98 

Today's Price Range

1.021.19

52W Range

0.40513.91

5 Year PE Ratio Range

-4.90-8.40

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
103.70%
1 Month
97.27%
3 Months
135.90%
6 Months
16.81%
1 Year
-69.86%
3 Years
-92.32%
5 Years
-91.89%
10 Years
-

TickerPriceChg.Chg.%
ATNX1.100.00000.00
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
18.00
-175.40
-171.40
-220.50
-79.98
RevenueValueIndustryS&P 500US Markets
86.96M
0.78
13.16
37.94
Earnings HistoryEstimateReportedSurprise %
Q02 2022-0.13-0.23-76.92
Q01 2022-0.16-0.24-50.00
Q04 2021-0.04-0.29-625.00
Q03 2021-0.41-0.3319.51
Q02 2021-0.41-0.3319.51
Q01 2021-0.37-0.2727.03
Q04 2020-0.42-0.53-26.19
Q03 2020-0.46-0.444.35
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.13-30.00Negative
9/2022 QR-0.0450.00Positive
12/2022 FY-0.48-9.09Negative
12/2023 FY-0.0925.00Positive
Next Report Date-
Estimated EPS Next Report-0.13
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume2.74M
Shares Outstanding121.61K
Shares Float89.95M
Trades Count7.94K
Dollar Volume3.05M
Avg. Volume2.17M
Avg. Weekly Volume3.96M
Avg. Monthly Volume1.27M
Avg. Quarterly Volume1.28M

Athenex Inc. (NASDAQ: ATNX) stock closed at 1.1 per share at the end of the most recent trading day (a 15.18% change compared to the prior day closing price) with a volume of 4.64M shares and market capitalization of 133.77M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 581 people. Athenex Inc. CEO is Johnson Y.N. Lau.

The one-year performance of Athenex Inc. stock is -69.86%, while year-to-date (YTD) performance is -19.12%. ATNX stock has a five-year performance of -91.89%. Its 52-week range is between 0.4051 and 3.91, which gives ATNX stock a 52-week price range ratio of 19.83%

Athenex Inc. currently has a PE ratio of -0.30, a price-to-book (PB) ratio of 1.75, a price-to-sale (PS) ratio of 0.78, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -67.77%, a ROC of -70.93% and a ROE of -205.18%. The company’s profit margin is -79.98%, its EBITDA margin is -171.40%, and its revenue ttm is $86.96 Million , which makes it $0.78 revenue per share.

Of the last four earnings reports from Athenex Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.13 for the next earnings report. Athenex Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Athenex Inc. is Moderate Buy (2), with a target price of $3, which is +172.73% compared to the current price. The earnings rating for Athenex Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Athenex Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Athenex Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 32.53, ATR14 : 0.10, CCI20 : 328.48, Chaikin Money Flow : 0.40, MACD : 0.08, Money Flow Index : 92.95, ROC : 62.36, RSI : 71.87, STOCH (14,3) : 93.85, STOCH RSI : 1.00, UO : 68.99, Williams %R : -6.15), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Athenex Inc. in the last 12-months were: Jinn Wu (Buy at a value of $248 600), Johnson Y.N. Lau (Buy at a value of $48 600), Jordan Kanfer (Buy at a value of $10 003), Rudolf Kwan (Buy at a value of $8 200)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
1 (20.00 %)
1 (20.00 %)
Moderate Buy
1 (33.33 %)
1 (20.00 %)
1 (20.00 %)
Hold
1 (33.33 %)
3 (60.00 %)
3 (60.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.40
Moderate Buy
2.40

Athenex Inc.

Athenex Inc is a global biopharmaceutical company. It is dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer. The company's operating segment includes the Oncology Innovation Platform; Global Supply Chain Platform and Commercial Platform. It generates maximum revenue from the Commercial Platform segment. Commercial Platform segment includes APD, which focuses on the manufacturing, distribution, and sales of specialty pharmaceuticals. Geographically, it derives a majority of revenue from the United States and also has a presence in Spain; Austria; India; China; the United Kingdom and Other foreign countries.

CEO: Johnson Y.N. Lau

Telephone: +1 716 427-2950

Address: 1001 Main Street, Buffalo 14203, NY, US

Number of employees: 581

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

73%27%

Bearish Bullish

62%38%

Bearish Bullish

57%43%

TipRanks News for ATNX


News

Stocktwits